Armata Pharmaceuticals Inc (ARMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 2,510 | 789 | 1,085 | 1,159 | 2,169 |
| Gross Profit | 2,510 | 789 | 1,085 | 1,159 | 2,169 |
| Operating Expenses | 12,822 | 9,574 | 14,908 | 8,935 | 9,013 |
| Operating Income | -10,312 | -8,785 | -13,823 | -7,776 | -6,844 |
| Interest Expense | 6,634 | 5,559 | 4,834 | 4,346 | 3,808 |
| Other Income | 91,087 | -101,002 | -105,641 | -14,553 | -5,643 |
| Pre-tax Income | 74,141 | -115,346 | -124,298 | -26,675 | -16,295 |
| Net Income Continuous | 74,141 | -115,346 | -124,298 | -26,675 | -16,295 |
| Net Income | $74,141 | $-115,346 | $-124,298 | $-26,675 | $-16,295 |
| EPS Basic Total Ops | 2.02 | -3.16 | -3.43 | -0.74 | -0.45 |
| EPS Basic Continuous Ops | 2.02 | -3.16 | -3.43 | -0.74 | -0.45 |
| EPS Diluted Total Ops | -0.27 | -3.16 | -3.41 | -0.74 | -0.45 |
| EPS Diluted Continuous Ops | 1.20 | -3.16 | -3.50 | -0.74 | -0.45 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.39 | -0.51 | -0.42 | -0.32 |
| EBITDA(a) | $-9,721 | $-8,328 | $-13,405 | $-7,406 | $-6,478 |